Daniel B Soland is Director of DBV Technologies S.A.. Currently has a direct ownership of 20,000 shares of DBVT, which is worth approximately $10,200. The most recent transaction as insider was on Aug 01, 2023, when has been sold 15,000 shares (Ordinary Shares) at a price of $1.62 per share, resulting in proceeds of $24,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20K
0% 3M change
0% 12M change
Total Value Held $10,200

DANIEL B SOLAND Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 01 2023
BUY
Open market or private purchase
$24,300 $1.62 p/Share
15,000 Added 42.86%
20,000 Ordinary Shares

Also insider at

KALV
KalVista Pharmaceuticals, Inc. Healthcare
IDRA
IDERA PHARMACEUTICALS, INC. Healthcare
ACAD
ACADIA PHARMACEUTICALS INC Healthcare
DBS

Daniel B Soland

Director
Exton, PA

Track Institutional and Insider Activities on DBVT

Follow DBV Technologies S.A. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DBVT shares.

Notify only if

Insider Trading

Get notified when an Dbv Technologies S.A. insider buys or sells DBVT shares.

Notify only if

News

Receive news related to DBV Technologies S.A.

Track Activities on DBVT